Atlas Venture Fund Xi, L.P. is > 10% Shareholder of Third Harmonic Bio, Inc.. Currently has a direct ownership of 594,096 shares of THRD, which is worth approximately $7.72 Million. The most recent transaction as insider was on Sep 19, 2022, when has been sold 300,000 shares (Common Stock) at a price of $17.0 per share, resulting in proceeds of $5,100,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 594K
0% 3M change
0% 12M change
Total Value Held $7.72 Million

Atlas Venture Fund XI, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 19 2022
BUY
Open market or private purchase
$5,100,000 $17.0 p/Share
300,000 Added 2.83%
10,313,763 Common Stock
Sep 19 2022
BUY
Conversion of derivative security
-
7,066,470 Added 92.24%
594,096 Common Stock

Also insider at

DAWN
Day One Biopharmaceuticals, Inc. Healthcare
DYN
Dyne Therapeutics, Inc. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
IKNA
Ikena Oncology, Inc. Healthcare
AVF

Atlas Venture Fund Xi, L.P.

> 10% Shareholder
Cambridge, MA

Track Institutional and Insider Activities on THRD

Follow Third Harmonic Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells THRD shares.

Notify only if

Insider Trading

Get notified when an Third Harmonic Bio, Inc. insider buys or sells THRD shares.

Notify only if

News

Receive news related to Third Harmonic Bio, Inc.

Track Activities on THRD